Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound vs. Fluoroscopy Guided Erector Spinae Plane Block in Postherpetic Neuralgia: A Prospective Study.

Journal of clinical medicine·2026
Same author

Spinopelvic Alignment as an Associated Factor of Short-Term Diagnostic Response to Lumbar Medial Branch Block: A Prospective Study.

Journal of clinical medicine·2026
Same author

Clinical Outcomes of Intra-Articular Ozone Injections in Hip Osteoarthritis: A Retrospective Study Comparing Different Injection Frequencies.

Journal of clinical medicine·2026
Same author

Genetic and Epigenetic Aberrations of <i>SOX7</i> in Newly Diagnosed and Relapsed Multiple Myeloma as Well as Related Neoplasms.

Current issues in molecular biology·2025
Same author

Adipose derived stromal vascular fraction cells therapy in hemophilic arthropathy: A case report.

Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology·2025
Same author

Correction: Potential diagnostic and prognostic biomarkers of pediatric Burkitt lymphoma identified through miRNA expression profiling.

Pediatric research·2024

Related Experiment Video

Updated: Jun 13, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Superficial venous thrombophlebitis caused by rocuronium.

Can Eyigor1, Arda Ceylan, Fusun Demir

  • 1Anesthesiology Department, Faculty of Medicine, Pain Clinic, Ege University, 35100, Bornova, Izmir, Turkey. can.eyigor@yahoo.com.tr

Journal of Anesthesia
|April 23, 2010
PubMed
Summary

Rocuronium injection causes significant pain and withdrawal movements in patients during anesthesia induction. This study suggests direct venous injury may contribute to rocuronium-related pain and subsequent thrombophlebitis.

More Related Videos

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
04:30

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Published on: March 8, 2024

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

Related Experiment Videos

Last Updated: Jun 13, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model
05:44

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
04:30

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Published on: March 8, 2024

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Rocuronium is a common neuromuscular blocking agent used in anesthesia induction.
  • Significant patient-reported pain and withdrawal movements are known side effects of rocuronium administration.

Observation:

  • The risk factors for rocuronium-induced pain and withdrawal movements are not well-understood.
  • The potential for these reactions to cause venous sequelae like erythema or thrombophlebitis has not been systematically investigated.

Findings:

  • In observed cases, patients experienced visible reactions following rocuronium injection.
  • Both patients in the study were diagnosed with superficial thrombophlebitis, indicating a venous complication.

Implications:

  • The findings suggest that direct venous injury may be a contributing factor to rocuronium-related pain.
  • Further investigation into the mechanism of rocuronium-induced venous injury is warranted to improve patient safety during anesthesia.